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ABSTRACT
Plants and many lower organisms, but not mammals, express
alternative oxidases (AOXs) that branch the mitochondrial respiratory
chain, transferring electrons directly from ubiquinol to oxygen without
proton pumping. Thus, they maintain electron flow under conditions
when the classical respiratory chain is impaired, limiting excess
production of oxygen radicals and supporting redox and metabolic
homeostasis. AOX fromCiona intestinalis has been used to study and
mitigate mitochondrial impairments in mammalian cell lines,
Drosophila disease models and, most recently, in the mouse, where
multiple lentivector-AOX transgenes conferred substantial expression
in specific tissues. Here, we describe a genetically tractable mouse
model in which Ciona AOX has been targeted to theRosa26 locus for
ubiquitous expression. The AOXRosa26 mouse exhibited only subtle
phenotypic effects on respiratory complex formation, oxygen
consumption or the global metabolome, and showed an essentially
normal physiology. AOXconferred robust resistance to inhibitors of the
respiratory chain in organello; moreover, animals exposed to a
systemically applied LD50 dose of cyanide did not succumb. The
AOXRosa26 mouse is a useful tool to investigate respiratory control
mechanisms and to decipher mitochondrial disease aetiology in vivo.
KEY WORDS: Mitochondria, Mitochondrial disease, Respiratory
chain, Alternative oxidase
INTRODUCTION
The mitochondrial system for oxidative phosphorylation (OXPHOS)
comprises four multisubunit complexes supporting stepwise
respiratory electron flow from primary electron acceptors to
oxygen, and a fifth complex (ATP synthase) that uses the proton
gradient thereby generated across the inner mitochondrial membrane
to synthesize ATP. In many lower organism and plants, alternative
oxidases (AOXs) are expressed that branch the mitochondrial
respiratory chain, thus transferring electrons directly from ubiquinol
to oxygen in a non-proton-motive manner. AOXs are absent in
mammals (Young et al., 2013) (Fig. 1A). Their main physiological
role is to maintain electron flow under conditions when the classical
respiratory chain is impaired, limiting excess production of oxygen
radicals and supporting redox and metabolic homeostasis. Because
AOX is also found in some invertebrate phyla (McDonald et al.,
2009), we have proposed that its expression in commonly studied
animal models could be used to elucidate the pathophysiology
underlying mitochondrial OXPHOS disorders, providing a rational
basis for its eventual implementation in therapeutic applications
(Rustin and Jacobs, 2009; El-Khoury et al., 2014).
In earlier studies, AOX from the tunicate Ciona intestinalis, a
sister group to the vertebrates, was shown to be expressible and
catalytically active in human cells (Hakkaart et al., 2006). It was
found to alleviate the deleterious consequences of toxic or
pathological inhibition of the downstream portion of the
mitochondrial respiratory chain (Hakkaart et al., 2006; Dassa
et al., 2009), specifically OXPHOS complexes III (cIII) and IV
(cIV), which AOX bypasses. A cDNA encoding Ciona AOX was
subsequently shown to be ubiquitously expressible in Drosophila,
without eliciting any harmful phenotypic effects (Fernandez-Ayala
et al., 2009). In the fly, AOX expression was able to compensate a
range of pathological phenotypes at the whole-organism level,
including lethality caused by OXPHOS poisons such as antimycin
A or cyanide (Fernandez-Ayala et al., 2009), locomotor disturbance
or neurodegeneration caused by cIV knockdown (Kemppainen
et al., 2014) or other causes of neurodegeneration mimicking
Parkinson’s (Fernandez-Ayala et al., 2009; Humphrey et al., 2012)
or Alzheimer’s (El-Khoury et al., 2016) diseases.
The potential for using AOX to study mitochondrial
pathophysiology at the whole-organism level in mammals has been
demonstrated using lentivector transduction, creating a transgenic
mouse expressing Ciona AOX in multiple tissues (El-Khoury et al.,
2013). Notably, harmful phenotypes were again not seen, despite
widespread transgene expression. However, the methodological
issues arising from the nature of that model have precluded its
widespread use. On insertion of AOX transgenes at multiple genomic
sites in themodel, none of them individually conferred expression at a
high level or in all tissues. Thus, the model could not be combinedReceived 14 September 2016; Accepted 30 November 2016
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with genetic disease models or other mouse mutants, could not be
practically transferred into other strain backgrounds, and its long-term
maintenance was essentially impossible.
Here, we report the creation of a genetically tractable transgenic
mouse that ubiquitously expresses a single copy of Ciona AOX at
substantial levels, after targeted insertion into the Rosa26 locus. The
Rosa26 knock-in gave rise to a functional enzyme, which conferred
resistance to respiratory poisons. Surprisingly, comprehensive
phenotyping revealed only minor, biologically inconsequential
effects of AOX expression in the AOXRosa26 mouse. The new model
offers great promise as a tool for elucidating the mechanisms of
mitochondrial pathologyandcharting theway towards future therapies.
RESULTS
Construction of AOXRosa26mice
To create a genetically tractable mouse model ubiquitously
expressing Ciona AOX, we used gene targeting into the
ubiquitously active Rosa26 locus (Hitoshi et al., 1991) in
mouse embryonic stem cells (ESC) (Soriano, 1999; Srinivas
et al., 2001). Previous authors have reported no detectable
pathological alterations arising from insertions at this locus
(Friedrich and Soriano, 1991; Zambrowicz et al., 1997), and
transgene expression seems to be stable (Zambrowicz et al.,
1997). To boost expression from the Rosa26 locus, we
incorporated the synthetic CAG enhancer-promoter into the
construct (Fig. 1B; Fig. S1), which enhances expression several-
fold (Nyabi et al., 2009; Chen et al., 2011). After verification
of the insertion in ESCs by Southern blotting (Fig. S1B,C),
a chimeric line was established via blastocyst injection, with
subsequent elimination of the positive-selectable (neomycin
resistance) cassette (Fig. S1A,B) by Flp recombination in vivo,
following germ-line transmission. Founders were backcrossed
over more than seven generations to strain C57Bl/6J, with
transgene presence checked at each step by PCR (Fig. S1D). The
rate of transmission of the AOX transgene from heterozygous
parents of either sex did not significantly deviate from 50%
(Fig. 1C), nor was there any significant parent-of-origin effect on
litter size (Fig. 1C). The progeny sex ratio was also unaffected by
the AOX transgene (Fig. 1D).
AOX is ubiquitously expressed in the AOXRosa26mouse
Northern blotting (Fig. 1E) confirmed widespread, though somewhat
uneven, expression with highest AOX mRNA levels in heart and
skeletal muscle, but lower expression in brain, taking account of the
Fig. 1. Construction and characterization of AOXRosa26 mice. (A) Schematic diagram of the mitochondrial OXPHOS system, showing the five standard
OXPHOS complexes (I-V), the diffusible electron carriers ubiquinone (Q) and cytochrome c (c), and the passage of electrons and protons resulting ultimately in
the synthesis of ATP fromADPand inorganic phosphate (Pi). The additional presence of AOX, whether supplied transgenically or in organisms naturally endowed
with it, provides an alternative route for the reoxidation of ubiquinol bymolecular oxygen, without proton pumping. (B) Schematic diagram of inserted Rosa26-AOX
expression construct, following removal of additional elements (i.e. DTA negative selectable marker upon targeted integration, and neomycin resistance cassette
following FRT-mediated excision in vivo). Remaining elements are the CAG promoter, AOX coding sequence and β-globin intron and poly(A) addition signal
(βGi+pA). For full details see Fig. S1A. (C) Transmission rate of AOX transgenes (based on PCR) and litter sizes, according to sex of AOX-hemizygous parent.
Transmission rates from male (n=93, 12 crosses) and from female (n=43, 6 crosses) were not significantly different from each other (Student’s t-test, P>0.05,
mean±s.d.) or from Mendelian expectation of 50% (chi-squared test). Litter sizes produced by AOX-hemizygous males and females also showed no significant
difference (Student’s t-test, P>0.05). (D) Sex (% of males) of transgenic and wild-type progeny of hemizygous AOXRosa26 mice (n=136, 18 crosses), again
showing no significant differences (Student’s t-test, P>0.05, mean±s.d.). (E) Northern blot showing AOX expression in RNA (10 μg) from tissues of one-year-old,
male, hemizygous AOXRosa26 mice and wild-type (wt) littermate controls: He, heart; Lu, lung; Li, liver; Br, brain; Ki, kidney; Sp, spleen; Te, testis; Sk, skeletal
muscle. The blot was reprobed for Atp5b mRNA as well as mitochondrial 12S and cytosolic 18S rRNAs as loading controls. RNA molecular weights were
extrapolated from rRNA migration in the ethidium bromide-stained gel.
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loading controls. At the protein level, expression seemed more
uniform, but was again highest in heart, skeletal muscle and pancreas,
and lowest in brain (Fig. 2A; Fig. S2). Brain expression was highest in
newborn mice (Fig. S2C), but declined substantially by one month of
age (Fig. S2C). As expected, AOX expression was higher in
homozygotes compared with heterozygous animals (Fig. S2D). The
enzyme was found to be associated with the membrane fraction of
isolated mitochondria after carbonate extraction (Fig. S2E), albeit less
tightly bound than some integral membrane proteins of the OXPHOS
complexes, such as subunit 1 of cIV (Mtco1).
In each tissue tested, the expression of representative subunits
of the five OXPHOS complexes was essentially unaffected by
AOX expression (Fig. 2A; Fig. S2A). Moreover, the overall
structure of the respiratory membrane, specifically its organization
into supercomplexes, was similarly unaltered, based on blue-native
electrophoresis (BNE) followed by in-gel histochemistry of heart
mitochondria (Fig. 2B), and on BNE combined with western blots
for OXPHOS subunits, for eight different tissues (Fig. S2F). In BNE
gels, AOX itself migrated mainly at the size of a dimer and as
multimers thereof (Fig. S2F,G), rather than associating specifically
with any other respiratory complex. In each tissue tested, the
mobility of the respiratory chain complexes detected by BNE was
identical to that in controls (Fig. S2F). Principal component analysis
of metabolite levels in skeletal muscle (Fig. 2C) and heart
(Fig. S2H) showed no consistent effect of AOX expression, nor
did any of 100 individual metabolites analyzed show any significant
difference (Tables S1, S2).
AOX is functional in AOXRosa26mice
We conducted respirometry to determine whether AOX is
enzymatically functional in the AOXRosa26 knock-in mice.
Mitochondria from six tissues (Fig. 3) were tested in a standard
protocol for oxygen consumption in the presence of complex I-, II-
and IV-linked substrates, successively using inhibitors of cI
(rotenone), cIII (antimycin A), AOX (n-propyl gallate) and cIV
(cyanide or azide). Therewere no significant differenceswhen oxygen
consumptionwas comparedwith that frommitochondria of wild-type
littermates, except for substrate oxidation in the presence of antimycin
A (i.e. mediated by AOX), which was significant for all tissues tested
except brain, where expression was low. Mitochondria from tissues
of AOXRosa26 mice other than brain showed antimycin A-resistant
(AOX-dependent) oxygen consumption between 30% and 70% of
the uninhibited level driven by succinate (Fig. 3A), similar also to
preliminary measurements in the founder mouse (Fig. S3A). In heart
mitochondria from AOX-expressing compared with control mice,
antimycin A- and azide-resistant substrate oxidation was evident
across a wide range of drug concentrations (Fig. S3B). Compared
with littermate controls, mitochondrial ROS production driven by
succinate was greatly decreased (Fig. 3B). Interestingly, this was only
significant in the absence of rotenone, implicating AOX in providing
Fig. 2. AOXRosa26mice show broad AOX expression and normal metabolism. (A) Western blots of 20 μg total protein extracts from the indicated tissues (He,
heart; Tm, thigh muscle; Mm, masseter muscle; Pa, pancreas; Lu, lung; Li, liver; Ki, kidney; Sp, spleen; Ce, cerebrum; Cb, cerebellum; Sg, salivary gland; Te,
testis) of 54-week-old male hemizygous AOXRosa26 (+) and wild-type littermate control (–) mice, probed for AOX and for representative subunits of the five
OXPHOS complexes (see Materials and Methods, protein molecular weights extrapolated from markers). For Ponceau S staining of the membranes see
Fig. S2B. See also Fig. S2A,C,D. (B) BNE gels of mitochondrial membrane proteins from hemizygous AOXRosa26 (+) and wild-type littermate control (–) mice,
stained with Coomassie Blue (CB) or probed by in-gel histochemistry for the indicated OXPHOS complexes. * denotes the migration of the respective monomeric
complexes. Assignment of mitochondrial complexes (I, cI; III2, dimeric cIII; IV, cIV; V, cV; S1, respiratory supercomplexes containing cI, dimeric cIII and one copyof
cIV) is based on protein molecular weights extrapolated from the migration of the complexes from bovine heart mitochondria, whose subunit composition is
known. (C) Principal component analysis of metabolome data from skeletal muscle of hemizygous AOXRosa26 (red circles) and wild-type littermate control mice
(green circles). The two sets of analysed data overlap, apart from two minor outliers from the control group. See also Fig. S2H.
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an alternative pathway for succinate oxidation other than reverse
electron transport through cI.
AOXRosa26mice exhibit normal physiology
The high level of AOX expression, capable of replacing a large
fraction of electron flow when cIII/IV is inhibited, raised the question
of potentially deleterious consequences under normal physiological
conditions. Surprisingly,AOXRosa26mice of both sexeswere similar in
size to littermate controls and gained weight normally during
development (Fig. 4A). Muscle and heart functions showed no
significant differences from littermate controls, based on standard
assays of grip strength (Fig. 4B), treadmill performance (Fig. 4B),
cardiac ejection fraction (Fig. 4C) and left ventricular mass (LVM;
Fig. 4C), conducted on mice of different ages. To complement these
data we implemented a comprehensive phenotyping, using the
resources of the German Mouse Clinic (https://www.mouseclinic.de,
search ‘phenomap’; hereafter referred to as ‘GMCPhenomap’). This
analysis covered metabolic, behavioural, morphological,
immunological, cardiac and neurological parameters, amongst
others. None of the parameters tested showed substantial or
systematic deviations from littermate controls.
AOXconfers protection against anLD50dose of systemically
delivered cyanide
Despite the absence of any meaningful phenotype under standard
(non-stressful) physiological conditions, we reasoned that the
ubiquitous expression (Fig. 2) of functional AOX (Fig. 3) should
confer whole-organism resistance to a respiratory poison targeting
cIII or cIV. Sample cohorts of female mice were thus tested for their
response to systemically administered potassium cyanide at ∼LD50
(Yamamoto, 1995), with evaluation of survival after 1, 24 and 48 h.
All five AOXRosa26 transgenic mice tested survived the treatment,
whereas three of six littermate controls succumbed as expected
(Fig. 5). Although the sample sizes are small, hence indicative rather
than definitive, the result is consistent with protection against
cyanide at the whole-organism level.
DISCUSSION
In this study we successfully engineered mice for stable, ubiquitous
expression of Ciona AOX, via a single-copy insertion into the
Rosa26 locus, controlled by the synthetic CAG promoter. AOX
protein was widely expressed and enzymatically functional when
tested in the presence of antimycin A in organello. AOX expression
produced negligible phenotypic effects under standard physiological
conditions, but seemed able to protect mice from the lethal effects of
injected cyanide. The AOXRosa26 mouse provides a genetically
tractable tool for analyzing the pathophysiology of a wide spectrum
of diseases proposed to be linked to mitochondrial respiratory
dysfunction.
The AOXRosa26mouse is a genetically tractable model
The ‘MitAOX’ transgenic mice, previously generated by lentivector
transduction (El-Khoury et al., 2013), provided a preliminary
indication that widespread Ciona AOX expression in the mouse is
not harmful. However, owing to the multi-copy nature of the
inserted transgene at different genomic sites, as well as varying
expression levels, MitAOX mice were not suitable for studies using
genetic disease models. To avoid these problems, we created a
revised model containing a single insertion of AOX cDNA at the
Rosa26 locus on chromosome 6. We demonstrated (Fig. 1) that the
Fig. 3. AOX is enzymatically functional in mitochondria from AOXRosa26 mice. (A) Respirometry (oxygen consumption in the indicated units) from isolated
mitochondria prepared from the indicated tissues of hemizygous AOXRosa26 mice and wild-type littermate controls, as shown; means±s.d. of three biological
replicates in each case. Note the different scales. 1 (Mal) – rotenone-sensitive oxidation of malate in the presence of glutamate, pyruvate and ADP; 2 (Succ) –
antimycin A- plus n-propyl gallate-sensitive succinate oxidation; 3 (AOX) – rate of n-propyl gallate-sensitive, antimycin A-insensitive succinate oxidation;
4 (TMPD) – rate of ascorbate-reduced TMPD oxidation. For further details see Materials and Methods. See Fig. S3C for respiratory control ratio in these samples.
(B) ROS production, measured as H2O2 output, from heart mitochondria of AOXRosa26 mice and wild-type littermates, as indicated, driven by the indicated
substrates or inhibitors (succ, succinate; rot, rotenone; pyr, pyruvate; mal, malate). #P<0.05 or *P<0.001 between given pairs of control and AOXRosa26 values,
Student’s t-test, means±s.d. Note that it is not possible to verify that this effect depends on the enzymatic activity of AOX, because the AOX inhibitor, n-propyl
gallate, is itself a potent antioxidant.
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introduced AOX gene is stably transmitted in a Mendelian manner,
remains active beyond at least seven generations of backcrossing to
strain C57Bl/6J, shows no parent-of-origin or sex-specific lethality,
and is widely expressed. The AOX transgene can, in principle, be
transferred to any desired strain background suitable for
combination with a given genetic model of disease, although our
current analysis was confined to the C57Bl/6J genetic background.
We expect that the AOXRosa26 mouse will become a versatile model
for studying the nature of mitochondrial involvement in disease-like
phenotypes.
AOX seems inert under standard physiological conditions
Although AOX was enzymatically functional in the presence of
antimycin A in organello, our data indicate that the metazoan
enzyme is functionally inert under standard physiological
conditions, as suggested previously (Hakkaart et al., 2006;
Fernandez-Ayala et al., 2009; El-Khoury et al., 2013). Several
lines of evidence support this conclusion: (1) any substantial
contribution by the non-proton-motive AOX to respiratory electron
flow should manifest in a significantly decreased respiratory control
ratio in respirometric measurements in organello. However, we did
not observe any significant alteration in our tissue survey at least for
cI-linked substrates and within the detection limits of the method
applied (Fig. S3C). (2) Inefficient mobilization of nutritional
resources by AOX-expressing mice should alter metabolic
parameters in vivo. However, there were no differences in whole
body weight (Fig. 4A), fat or lean body mass determined by
nuclear magnetic resonance (NMR) (see GMC Phenomap),
or physiological parameters determined by indirect calorimetry,
including food intake, body temperature, oxygen/CO2 exchange or
activity (see GMC Phenomap). (3) No significant differences in
heart performancewere detected by electro- or echocardiography, or
MRI (Fig. 4C; GMC Phenomap), although the heart is the most
energy-demanding tissue and showed the highest AOX expression.
Low AOX expression in brain
The relatively low expression of the AOX transgene in adult brain
(Fig. 1E, Fig. 2A, Fig. S2A,D) is somewhat puzzling, given
previous reports. The CAG promoter has previously been used to
drive transgene expression at a high level in the mouse brain during
development (Liu et al., 2014) as well as in the adult (Ida-
Hosonuma et al., 2002; Kim et al., 2013), and the Rosa26 locus
efficiently drives expression in the brain (Banares et al., 2005; Hitz
et al., 2007; Delaunay et al., 2009). Moreover, we also achieved
substantial expression in the brains of MitAOX transgenic mice
(El-Khoury et al., 2013), using the same CAG promoter.
Fig. 4.AOXRosa26mice exhibit normal physiology. (A) Mean weight±s.d. of hemizygousAOXRosa26 and wild-type littermate control mice of the sexes indicated,
during post-natal development, n≥8 for each sex and genotype analysed. (B) Muscle parameters of male hemizygous AOXRosa26 and wild-type littermate control
mice of the ages indicated; means±s.d. For each group analysed n≥4 (grip strength) or n≥6 (treadmill). (C) Cardiac parameters, as indicated, of hemizygous
AOXRosa26 and wild-type littermate control mice of the sex and ages indicated; means±s.d., n≥4 for each group analysed. All data obtained by echocardiography
except ejection fraction at 10 w of age, which used MRI, n≥5. There were no significant differences between AOXRosa26 and wild-type values for any parameter
measured (Student’s t-test, P>0.05).
Fig. 5. Sampled AOXRosa26 mice are protected against cyanide toxicity
in vivo. Survival curves of samples of hemizygous female AOXRosa26 mice
(n=5) and wild-type controls (n=6) treated systemically with KCN as described
in Materials and Methods. Note that the experiment would need to be
conducted on a much greater scale to generate fully reliable statistics, but is
precluded by ethical considerations.
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Intriguingly, neonatal AOXRosa26 brains expressed substantially
more AOX at the protein level than adults (Fig. S2C), indicating that
the transgene can be active, but apparently regulated, in neural cells.
At present we do not have a convincing explanation for these
anomalies. However, the relatively low expression of AOX in the
adult brain seemed sufficient to protect against the lethality of
systemically delivered cyanide (Fig. 5), which can cross the blood-
brain barrier and has major toxic effects in the central nervous
system (Yamamoto and Tang, 1996; Reiter et al., 2010; Zhang et al.,
2015). It will be interesting to explore in greater depth the specific
physiological effects of this dose of cyanide and how these effects
are modified by AOX expression.
Lack of metabolic disturbance resulting from AOX
expression
The lack of any discernible, deleterious phenotype at the whole-
organism level arising fromAOX expression (Fig. 4; supplementary
Data), mirrors the lack of biochemical disturbance in the AOXRosa26
mouse. This was the case even in heart (Fig. 2A,B) and skeletal
muscle (Fig. 2A) tissues showing high levels of AOX expression.
The highly proteinaceous inner mitochondrial membrane is
organized into different subcompartments with distinct structures,
protein composition and biochemical functions (Vogel et al., 2006).
In particular, the supramolecular organization of the OXPHOS
system in supercomplexes is generally considered to maximize the
efficiency of electron flow (Acín-Pérez et al., 2008; Chaban et al.,
2014). We observed no structural (Fig. 2B) or functional (Fig. 3A)
disturbance of the endogenous respiratory membrane upon AOX
expression, which might reflect natural properties of Ciona AOX,
enabling it to reside in the mitochondria of its parent species.
Transgenic AOX seems to form homomeric complexes, rather than
associating with (and potentially disrupting) other OXPHOS
complexes. The electrophoretic mobility of the standard
OXPHOS complexes was indistinguishable from that in controls,
in all tissues tested (Fig. 2B; Fig. S2F,G). Our findings imply that
these multimers are themselves benign, although it remains
unknown whether AOX is structurally arrayed in a similar manner
in its natural context in Ciona. We reason that, by remaining
uncomplexed with other respiratory chain components, the enzyme
would be functionally adapted to act as a sink for electrons
transferred from diffusible quinols in the inner mitochondrial
membrane. Quinone reduction might arise from the operation of
diverse dehydrogenases, including, for example, cII, electron
transferring flavoprotein dehydrogenase, the mitochondrial
isoform of glycerol-3-phosphate dehydrogenase and
dihydroorotate dehydrogenase. Under normal physiological
conditions, diffusible quinols would be efficiently mopped up by
(dimeric) cIII, whether alone or attached to cIV as a supercomplex.
As in plants (Hoefnagel and Wiskich, 1998; Castro-Guerrero et al.,
2004), AOX would only become active at high quinol
concentrations, reflecting its lower affinity for quinols than cIII.
Thus, AOX would be brought into play only when quinols
accumulate as a result of inhibition or overload of the standard
respiratory pathway, as inferred previously in human cells (Dassa
et al., 2009). This hypothesis is also consistent with our observation
that AOX expression drastically decreases mitochondrial ROS
production by heart mitochondria in the presence of high levels of
succinate (Fig. 3B), which promotes reverse electron flow through
cI (Chouchani et al., 2014). Our observations suggest that AOX
might have dramatic consequences under stress, especially in heart
and other tissues where it is highly expressed. Tests of this
hypothesis will also reveal whether AOX could have beneficial roles
in future therapies (El-Khoury et al., 2014). A first demonstration of
the utility of AOXRosa26 mice has recently been published (Mills
et al., 2016), in which AOX was shown to confer resistance against
lethality in models of bacterial sepsis. Further trials, combining
AOXRosa26 with specific genetic disease models, should reveal the
extent to which AOX can alleviate the pathophysiology of
respiratory chain dysfunction. The AOXRosa26 mouse model
should have wide applications and is available for the research
community, upon request.
MATERIALS AND METHODS
Construction of targeting vector
Standard cloning and recombineering procedures (Liu et al., 2003;Warming
et al., 2005) were used to assemble the pRosa26-Aox targeting vector.
Briefly, PL451 was adapted to serve as AOX entry vector, by integrating
homology arms for the mouse Rosa26 locus (PL451-Rosa26) upstream and
downstream of the neomycin selection cassette. Ciona AOX (Hakkaart
et al., 2006) was integrated upstream of the selection cassette, and used to
co-transform recombineering-competent Escherichia coli (EL250) with a
Rosa26-targeting plasmid (pRosa26-DTA). Positive clones were selected
by kanamycin resistance (pRosa26-Aox), verified by PCR and sequencing,
and electroporated into v6.5 ESCs following linearization with SalI. After
negative (DTA, Diptheria toxin A) and positive (G418) selection,
homologous integration was verified by Southern blotting (Koetsier et al.,
1993) using gene-specific restriction enzymes and probes to distinguish the
wild-type and manipulated alleles (see supplementary Materials and
Methods and Fig. S1B,C for further details).
Creation of transgenic mice
ESC clones positive for integration were injected into blastocysts and
transferred to pseudopregnant mice. Chimeric males were then backcrossed
onto the C57Bl/6J strain background to generate heterozygous animals, and
subsequently bred with mice ubiquitously expressing FLP recombinase
(Rodríguez et al., 2000), in order to delete the neomycin selection cassette.
Mice were backcrossed (>7 generations) to C57Bl/6J females to obtain a
clean genetic background for all subsequent studies.
PCR genotyping of AOXRosa26mice
Crude DNA for genotyping was extracted from ear punches or tail cuts by
standard methods (proteinase K treatment, isopropanol precipitation and
overnight resuspension in TE at 56°C).Multiplex PCRgenotypingwas carried
out using primers Aox 317 s: 5′-GCGATGCAAGATGGAGGGTA-3′ plus
Aox 317 as: 5′-TGAATCCAACCGTGGTCTCG-3′ forAOX, and Rosa26_wt
s: 5′-GACCTCCATCGCGCACTCCG-3′ plus Rosa26_wt as: 5′-
CTCCGAGGCGGATCACAAGC-3′ for the wild-type Rosa26 locus, giving
respective products of 317 and 523 bp. PCR reactions of 20 μl contained
4 pmol of each primer, DMSO at 2% and 0.2 μl DyNazyme II (Thermo Fisher
Scientific), with cycle parameters of initial denaturation at 95°C for 5 min, then
39 cycles of denaturation at 95°C for 20 s, annealing at 56°C for 30 s and
extension at 72°C for 60 s, with final extension step at 72°C for 10 min,
followed by 1.5% agarose gel electrophoresis. See Fig. S1D for example gel.
RNA analysis
RNAwas prepared from dissected mouse tissues by bead homogenization in
700 μl (>10 volumes) of Trizol reagent (Sigma). After incubation for 5 min
at room temperature, samples were gently extracted with 0.2 volumes of
chloroform and centrifuged at 12,000 gmax for 15 min at 4°C. The upper
(aqueous) phase was decanted and RNA recovered by isopropanol
precipitation and centrifugation. Using standard procedures (Sambrook
et al., 1989), air-dried RNA pellets were resuspended in 20 μl RNase-free
water, fractionated on formaldehyde-agarose gels, blotted to Hybond-N+
membrane (GEHealthcare) in 10×SSC and hybridized to end-labelled DNA
oligonucleotide probes for AOX, mitochondrial 12S and cytosolic 18S
rRNA, and Atp5b mRNA, respectively 5′-CTTGACCCACTGTTTCTCA-
TCTAGCCG-3′, 5′-CATGGGCTACACCTTGACCT-3′, 5′-TCGAACCC-
TGATTCCCCGTCACCC-3′ and 5′-GGTGAATATGACCATCTCCCAG-
AACAAGC-3′.
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Protein analysis
For protein extraction, small pieces of fresh or frozen tissue from dissected
organs were placed in 500 μl of lysis buffer (50 mM Tris/HCl, 150 mM
NaCl, 1 mM EDTA, 1% Triton X-100, pH 7.4), containing a dissolved
protease inhibitor cocktail tablet (Pierce), in a 5 ml tube on ice. After
homogenization using a POLYTRON PT 1200 E Manual Disperser
(Ecoline), samples were incubated on ice for 30 min followed by
centrifugation at 14,000 gmax for 5 min at 4°C. Supernatants were saved
and protein concentration was measured using Bradford reagent (Bio-Rad)
before dilution into SDS-PAGE sample buffer for electrophoresis on SDS
12% polyacrylamide gels. After semi-dry transfer to PROTRAN
nitrocellulose membranes (PerkinElmer), western blots were probed using
primary antibodies for AOX [customized rabbit antibody, 21st Century
Biochemicals (Fernandez-Ayala et al., 2009), 1:40,000 in Tris-buffered
saline (TBST) containing 5% BSA] with secondary antibody peroxidase-
conjugated AffiniPure goat anti-rabbit IgG (Jackson ImmunoResearch,
111-035-144, 1:20,000). After stripping by two 20 min washes with
100 mM β-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl (pH 6.7), each
followed by blocking with TBST containing 5%milk for 30 min, blots were
reprobed for representative subunits of the OXPHOS complexes, using
Total OXPHOS Cocktail antibody [Abcam, ab110413, 1:250; visualizing
Sdhb (cII), Uqcrc2 (cIII), Mtco1 (cIV) and Atp5a (cV)], plus an antibody
against complex 1 subunit Ndufs3 (Mitosciences, ab14711, 1:4000), both
detected with peroxidase-conjugated AffiniPure goat anti-mouse IgG
(Jackson ImmunoResearch, 115-035-146, 1:1000) as secondary antibody.
Chemiluminescent detection used 20× LumiGLO Reagent and 20×
Peroxide from Cell Signaling Technology, according to manufacturer’s
recommendations. Enrichment of mitochondrial membranes, solubilisation
of mitochondrial complexes and BNE were carried out as described (Wittig
et al., 2006; Heidler et al., 2013). Mitochondrial complexes were stained
with Coomassie Blue (Wittig et al., 2006) and specific in-gel histochemical
staining for cI, cIV, and cV was performed as described previously (Wittig
et al., 2007). For immunodetection, BNE-gels were blotted onto PVDF
membranes and probed with antibodies against AOX (1:50,000) or
mitochondrial complexes (MitoProfile Total OXPHOS Rodent WB
Antibody Cocktail, Mitosciences, ab110413, 1:250) and cIV (1:1000;
Heidler et al., 2013).
Metabolomics
Metabolite analysis was conducted as described previously (Nikkanen et al.,
2016), using skeletal muscle from six hemizygous AOXRosa26 and six wild-
type littermate control mice (8-week-old males, all culled at a single time in
the morning). Briefly, targeted metabolomics was implemented by ultra-
performance liquid chromatography tandem mass-spectrometry using a
Waters XEVO-TQ-S mass spectrometer. Metabolites extracted with
acetonitrile were separated by hydrophilic liquid-interaction
chromatography, then analysed spectrometrically by multiple reaction
monitoring. Raw data were collected and analysed with TargetLynx
software (Waters), and metabolites quantified using internal standards and
calibration curves. For full details, see supplementary Materials and
Methods.
Bioenergetic experiments
For respirometry of mitochondria from different tissues, mice were
euthanised by cervical dislocation and organs were dissected and collected
into ice-cold PBS. Soft tissues were fine chopped (1 mm3) in ice-cold PBS
and hand-homogenized in 3 ml re-suspension buffer [225 mM sucrose,
75 mMD-mannitol, 10 mM Tris/HCl, 1 mM EGTA, 1 mg/ml bovine serum
albumin (BSA), pH 7.4], using a glass-teflon homogenizer (tight-fitting
pestle). Hard tissues (heart, skeletal muscle and kidney), chopped to a similar
size, were pre-treated with 3 ml (∼10 volumes) ice-cold trypsin-EDTA
[500 μg/ml trypsin (Difco), 0.5 mMEDTA, 10 μg/ml phenol red, pH 7.4] for
10 min, followed by blocking with 300 μl foetal bovine serum (Gibco/Life
Technologies) and recovery by low-speed centrifugation (40 gmax, 1 min, 4°
C) before homogenization. Homogenates were centrifuged at 1300 gmax for
5 min at 4°C, after which supernatants were collected and re-centrifuged at
17,000 gmax for 15 min at 4°C. The mitochondrial pellet was resuspended,
according to its size, in 75-250 μl ice-cold MiR05 buffer [0.5 mM EGTA,
3 mMMgCl2, 60 mM lactobionic acid (Aldrich, buffered to pH 7.0 with 5 M
KOH), 20 mM taurine (Sigma), 10 mM KH2PO4, 20 mM HEPES/KOH,
110 mM sucrose and 1 g/l fatty-acid free BSA (Sigma), pH 7.2 at room
temperature] and stored on ice until respirometry. Mitochondrial protein
content was assayed using Bradford reagent (Bio-Rad). Respirometry, using
an O2K oxygraph (Oroboros), was conducted in MiR05 buffer in a 2 ml
chamber, to which was added 50 or 100 µg of mitochondria according to the
tissue. Substrates and inhibitors were added in the following order: (1) 5 mM
sodium pyruvate+5 mM sodium glutamate+5 mM sodiummalate, (2) 4 mM
ADP, (3) 150 nM rotenone (Sigma), (4) 17 mM sodium succinate, (5)
22.5 ng/ml antimycin A (Sigma), (6) 200 µM n-propyl gallate (nPG, Sigma),
(7) 0.5 mM N,N,N′,N′-tetramethyl-p-phenylenediamine (TMPD, Sigma)
+2 mM sodium L-ascorbate, (8) 100 mM NaN3 or 1 mM KCN. The flux
values [pmol/(s×ml)] obtained from the trace were normalized to the amount
of mitochondrial protein. For measurements of ROS production, mouse heart
mitochondria were isolated essentially as described (Mela and Seitz, 1979),
with minor modifications: tissue was minced in 225 mM mannitol, 20 mM
MOPS, 75 mM sucrose, 1 mM EGTA, 0.5 mM dithiothretol, pH 7.4 and
hand-homogenized in 10 ml/g tissue of the same buffer containing 0.05%
Nagarse (Sigma). After addition of 30 ml of the original buffer, the
homogenate was centrifuged at 2000 gmax for 4 min at 4°C. The supernatant
was passed through cheesecloth and re-centrifuged at 12,000 gmax for 10 min.
The resulting pellet was resuspended in 225 mM mannitol, 20 mM MOPS,
75 mM sucrose, 0.1 mMEGTA, 75 mMKCl, pH 7.4. Mitochondrial protein
content was determined using the bicinchoninic acid assay (Wiechelman
et al., 1988), with BSA as standard. ROS production under conditions used
for respirometry was measured fluorimetrically using 5 µM Amplex Red
(Hydrogen Peroxide Assay Kit, Thermo Fisher Scientific) and 3 units/ml
horseradish peroxidase at 30°C, using a Carry Eclipse fluorimeter (Varian)
with excitation at 560 nm and detection at 590 nm (Zhou et al., 1997).
Mouse phenotyping
Mouse body weight was measured using a small electronic balance suitable
for rodents. Grip strength was measured using the BIO-GS3 apparatus
(Bioseb). Mice were placed on the platform until all four limbs were
engaged on the grid, and then pulled to measure the force generated. The
mean of three measurements was normalised to body weight (g/g) for each
animal tested. All animals were trained for three successive days before the
actual experiment. Endurance running was measured as previously (Yatsuga
and Suomalainen, 2012), as the run time on a standard running belt (Exer-
6M Treadmill, Columbus Instruments), set to reach a speed of 6.5 m/min in
steps of 0.5 m/min every 3 min. A stay of more than 5 s on the electrified
motivation grid (0.5 mA current) was considered as the end point of
each test. Cardiac parameters (ejection fraction, left ventricular mass)
were determined by echocardiography (Vevo 2100 system, FujiFilm
VisualSonics Inc.) or, where indicated in figure legends, by magnetic
resonance imaging (MRI), performed essentially as described elsewhere
(Ziebart et al., 2008). MRI data were analysed using OsiriX Imaging
Software (http://www.osirix-viewer.com/index.html). Comprehensive
phenotyping by the German Mouse Clinic (GMC) was conducted using
the protocols described and referenced at https://www.mouseclinic.de
(search ‘phenomap’). In all tests, mouse genotypes were blinded to the
experimenter and verified subsequently.
Systemic administration of cyanide
The procedure was implemented under contract by Luria Scientific
Industries, Herzliya, Israel (responsible scientist Dr Iris Maimon). Mice,
whose genotypes were blinded to the experimenter, were anesthetized with
3% isoflurane in an induction chamber, after which anaesthesia was
maintained by 2% isoflurane using a nose cone. Core temperature was kept
at 36.5°C using a heating pad. KCN was dissolved in distilled water at
10 mg/ml and delivered by IP injection to the mice at 8.5 mg/kg. Animals
were observed for 48 h for the onset of death, defined as apnea without
further respiratory effort or movement or palpable cardiac pulsation.
Ethical permits
All mouse breeding and experiments were approved by the national ethical
committee in Finland, under permits ESAVI/8766/04.10.07/2015 and ESAVI/
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2954/04.10.07/2015. Mouse experiments conducted under contract by Luria
Scientific Industries were approved by IACUC under assurance 7433J45,
07/22/2015.Maintenanceofmice inMagdeburgwas in accordwithprocedures
specifiedby theAnimalHealth andCareCommitteesof theOtto-von-Guericke
University, Magdeburg, and of the State of Sachsen-Anhalt, Germany.
Image processing
Images were optimized for brightness and contrast and cropped for clarity.
No other manipulations such as gamma corrections were made, nor was any
relevant information excluded by cropping. Full, original gel images are
available on request.
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advice and help, Anu Suomalainen and Brendan Battersby, for useful discussions,
and Troy Faithfull for critical reading of the manuscript.
Competing interests
The authors declare no competing or financial interests.
Author contributions
H.T.J., T.B., P.R. and M.S. jointly conceived the project and developed the strategy to
create the AOXRosa26 mouse. M.S. supervised and coordinated the laboratory work,
which was conducted by M.S., P.K.D., E.D., K.M.H., Y.Z., I.S., I.W., J.H., Z.G., T.G.,
J.N., V.V., A.W. and F.N.G. H.F., V.G.-D. and M.H.d.A. implemented comprehensive
phenotyping in collaboration with their colleagues from the German Mouse Clinic.
H.T.J. compiled the manuscript and figures with assistance from all authors.
Funding
This work was supported by funding from the European Research Council
(Advanced Grant 232738 to H.T.J.), Academy of Finland (Suomen Akatemia)
Terveyden Tutkimuksen Toimikunta (grant 272376); Tampere University
(Tampereen Yliopisto) Hospital Medical Research Fund; the Sigrid Juselius
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